Business

Axcan Appoints Steve Gannon Senior Vice President and Chief Financial Officer

Axcan Appoints Steve Gannon Senior Vice President and Chief Financial Officer.

articleTrailbreaker Resources LtdJanuary 20, 20064/company/trailbreaker-resources-ltd/news/axcan-appoints-steve-gannon-senior-vice-president-and-chief-financial-officer
Axcan Appoints Steve Gannon Senior Vice President and Chief Financial Officer

About this update from Trailbreaker Resources Ltd

[{"type":"text","content":"\n\n\n\n\nTSX SYMBOL (Toronto Stock Exchange): AXP\nNASDAQ SYMBOL (NASDAQ National Market): AXCA\n\nMONT-SAINT-HILAIRE, QC, Jan. 20 /CNW Telbec/ - Axcan Pharma Inc. (NASDAQ:\nAXCA - TSX: AXP) announced today the appointment of Steve Gannon as Senior\nVice President and Chief Financial Officer (CFO) in order to enhance its\nsenior financial team. This appointment will be effective April 3, 2006.\nMr. Jean VDezina, formerly CFO, will continue to serve in the role of Vice\nPresident, Finance.\n\"We are very pleased to welcome Mr. Gannon to the Axcan team. Steve\nbrings significant capital market experience to the Company, which will be\ninvaluable as Axcan moves to the next phase of its growth. We look forward to\nSteve's contribution to our activities,\" said Frank Verwiel, M.D., President\nand Chief Executive Officer of Axcan. \"With the growth of the Company, Jean\nVDezina will provide an increased focus on financial reporting excellence and\ncompliance in response to the increasingly complex regulatory and geographical\nenvironment,\" Dr. Verwiel added.\nAs Senior Vice President and CFO, Mr. Gannon will provide financial\noversight and guidance of Axcan's operations and growth opportunities, and\nenhance the capabilities of the organization by working closely with the\nfinancial markets. Mr. Gannon brings extensive financial experience in\ncorporate growth initiatives such as acquisitions, corporate alliances and\npartnerships within biotechnology and pharmaceutical companies. Mr. Gannon has\nheld a number of senior financial roles in AstraZeneca and most recently,\nserved as Chief Financial Officer of CryoCath Technologies Inc. Mr. Gannon\nreceived his Bachelor of Commerce from the University of Concordia, and his\nchartered accountant's designation (CA) in 1985.\nJoining Axcan in December 1992, Jean VDezina has been instrumental in\nmanaging Axcan's financing activities through several rounds of private\nfinancing, as well as the Company's initial public offering in 1995 and the\nNASDAQ listing in 2000. He also implemented best practices in public company\nreporting, disclosure and financial control, and leads implementation of the\nCompany's Sarbanes-Oxley compliance measures worldwide. Enhancement of the\nsenior financial team, will allow him to concentrate fully on overall\ncompliance to applicable legislation, regulations...

More updates from Trailbreaker Resources Ltd